Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florin Mihaltan

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Expert Review of Pharmacoeconomics & Outcomes Research|April 19, 2014
Outcome measures for palliative oxygen therapy: relevance and practical utilitySabina Antoniu, Florin Mihaltan
Maedica|September 21, 2020
Possible Nutritional Interventions in COVID 19Anca Hancu, Florin Mihaltan
Maedica|February 23, 2023
Cannabis - a Rewritten History and Its Pulmonary ConsequencesFlorin Mihaltan, Andrada Nechita, Ancuta Constantin
Maedica|March 11, 2020
Asthma and Ultra-Processed FoodAnca Hancu, Florin Mihaltan, Gabriela Radulian
Expert Opinion on Investigational Drugs|July 12, 2008
Anti-TNF-alpha therapies in chronic obstructive pulmonary diseasesSabina A Antoniu, Florin Mihaltan, Ruxandra Ulmeanu
Expert Opinion on Pharmacotherapy|May 5, 2015
Efficacy of indacaterol as a single therapy versus salmeterol/fluticasone therapy in patients with milder chronic obstructive pulmonary diseaseUlmeanu Ruxandra, Sabina Antonela Antoniu, Florin Mihaltan, et al.
Expert Opinion on Pharmacotherapy|April 3, 2020
Evaluating revefenacin as a therapeutic option for chronic obstructive pulmonary diseaseSabina Antonela Antoniu, Ruxandra Rajnoveanu, Ruxandra Ulmeanu, et al.
Journal of Microbiological Methods|January 18, 2003
Rapid dot sputum and serum assay in pulmonary tuberculosisHenriette Stavri, Olga Moldovan, Florin Mihaltan, et al.
Scientific Reports|July 30, 2025
Sleep and modern life: a population-based studyMihaela Oros, Franck Soyez, Adina-Diana Moldovan, et al.
Expert Opinion on Pharmacotherapy|December 29, 2020
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic reviewSabina Antonela Antoniu, Ioana Buculei, Florin Mihaltan, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Expert Review of Pharmacoeconomics & Outcomes Research|April 19, 2014
Outcome measures for palliative oxygen therapy: relevance and practical utilitySabina Antoniu, Florin Mihaltan
Maedica|September 21, 2020
Possible Nutritional Interventions in COVID 19Anca Hancu, Florin Mihaltan
Maedica|February 23, 2023
Cannabis - a Rewritten History and Its Pulmonary ConsequencesFlorin Mihaltan, Andrada Nechita, Ancuta Constantin
Maedica|March 11, 2020
Asthma and Ultra-Processed FoodAnca Hancu, Florin Mihaltan, Gabriela Radulian
Expert Opinion on Investigational Drugs|July 12, 2008
Anti-TNF-alpha therapies in chronic obstructive pulmonary diseasesSabina A Antoniu, Florin Mihaltan, Ruxandra Ulmeanu
Expert Opinion on Pharmacotherapy|May 5, 2015
Efficacy of indacaterol as a single therapy versus salmeterol/fluticasone therapy in patients with milder chronic obstructive pulmonary diseaseUlmeanu Ruxandra, Sabina Antonela Antoniu, Florin Mihaltan, et al.
Expert Opinion on Pharmacotherapy|April 3, 2020
Evaluating revefenacin as a therapeutic option for chronic obstructive pulmonary diseaseSabina Antonela Antoniu, Ruxandra Rajnoveanu, Ruxandra Ulmeanu, et al.
Journal of Microbiological Methods|January 18, 2003
Rapid dot sputum and serum assay in pulmonary tuberculosisHenriette Stavri, Olga Moldovan, Florin Mihaltan, et al.
Scientific Reports|July 30, 2025
Sleep and modern life: a population-based studyMihaela Oros, Franck Soyez, Adina-Diana Moldovan, et al.
Expert Opinion on Pharmacotherapy|December 29, 2020
Pharmacological strategies for smoking cessation in patients with chronic obstructive pulmonary disease: a pragmatic reviewSabina Antonela Antoniu, Ioana Buculei, Florin Mihaltan, et al.
Pageof 5